Receives R&D Tax Refund
Receives R&D Tax Refund
Brisbane, Oct 14, 2016 AEST (ABN Newswire) - Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $420,460 from the Australian Tax Office for the Research and Development (R&D) Tax Incentive. This refund is from Anatara's 2014-15 research activities and future refunds will increase significantly. The company is in the process of finalising its 2015-16 tax claim.

Dr Bridges said "the R&D tax rebate is an important source of non-dilutive funding for the company and will provide an ongoing source of valuable funds for the company's R&D initiatives. The refund further strengthens Anatara's Balance Sheet".

About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) is developing therapeutics for gastrointestinal diseases in production animals and humans. Its lead product Detach(R) is a natural plant based product that aids in the control of diarrhoea and will help address global concerns around the overuse of antibiotics in production animals that is contributing to the rise of so-called "super bugs" that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.



Investor inquiries:
Dr Mel Bridges
Chairman & CEO, Anatara Lifesciences
Phone: +61-413-051-600

Dr Tracey Mynott
CSO, Anatara Lifesciences
Phone: +61-405-050-113

Media inquiries:
Jane Lowe
IR department
Phone: +61-411-117-774

Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 10) (Last 30 Days: 26) (Since Published: 1967) 

Anatara Lifesciences Ltd NEWS: RECENT VISITS (6736)

Research Report

Social Media